aboutus

Notifications

“Life is a phenomenon of gene expression, and its imbalance causes most of the diseases we know. The most effective tool to correct this imbalance is inevitably ‘gene’. Therefore, gene therapy technology is axiomatically the most effective treatment strategy that can fundamentally treat many diseases that were incurable in the past. We earnestly wish that the gene therapy technology we pursue will let us overcome life-threatening diseases in the near future.”

Prof. Suk Chul Bae, CEO of GeneCraft

30+ years of research on cancer treatment effect of RUNX3

(1991 – Now)

Professor, College of Medicine, Chungbuk National University

Director, Oncology Research Center, Chungbuk National University

Director, Creative Research Task of the Ministry of Science and Technology

Bio industry member of the National Science and Technology Committee

Researcher, International Center for Infectiology Research

Researcher, Kyoto University

Pharm.D., Seoul National University

Scientist of the Year award (2002)

Best Presentation Award – International Journal of Oncology

GeneCraft is a pre-clinical-stage biotech company dedicated to improving treatment and clinical outcomes for patients through gene therapy that harness the innate oncogene defense system.

GeneCraft is a pre-clinical-stage biotech company dedicated to improving treatment and clinical
outcomes for patients through gene therapy that harness the innate oncogene defense system.